Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene blue for inoperable cutaneous squamous cell carcinoma
IRCT20191228045924N9Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methylene blue in cutaneous squamous cell carcinoma (cSCC), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Wound size. Started Jan 2026; status: completed.
02
Drugs
methylene blue
03
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on IRCT20191228045924N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191228045924N9.